Compounds > cyproterone acetate
Page last updated: 2024-08-21

cyproterone acetate and Gender Dysphoria

cyproterone acetate has been researched along with Gender Dysphoria in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Conemans, EB; den Heijer, M; Fisher, AD; Kuijpers, SME; T'Sjoen, G; Wiepjes, CM1
Aranda, G; Fernández-Rebollo, E; Halperin, I; Hanzu, FA; Kalko, SG; Mora, M; Pradas-Juni, M1

Other Studies

2 other study(ies) available for cyproterone acetate and Gender Dysphoria

ArticleYear
Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study.
    The Journal of clinical endocrinology and metabolism, 2021, 09-27, Volume: 106, Issue:10

    Topics: Androgen Antagonists; Belgium; Cohort Studies; Cyproterone Acetate; Dose-Response Relationship, Drug; Female; Gender Dysphoria; Gender Identity; Hormone Replacement Therapy; Humans; Italy; Longitudinal Studies; Male; Netherlands; Sex Reassignment Procedures; Transsexualism; Treatment Outcome

2021
Effects of sex steroids on the pattern of methylation and expression of the promoter region of estrogen and androgen receptors in people with gender dysphoria under cross-sex hormone treatment.
    The Journal of steroid biochemistry and molecular biology, 2017, Volume: 172

    Topics: Adolescent; Adult; Anthropometry; Cyproterone Acetate; DNA Methylation; Drug Administration Schedule; Epigenesis, Genetic; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Follicle Stimulating Hormone; Gender Dysphoria; Humans; Luteinizing Hormone; Male; Prolactin; Promoter Regions, Genetic; Prospective Studies; Receptors, Androgen; RNA, Messenger; Sex Hormone-Binding Globulin; Signal Transduction; Testosterone

2017